Shaked Y - Search Results

1

The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study.

Goshen-Lago T, Szwarcwort-Cohen M, Benguigui M, Almog R, Turgeman I, Zaltzman N, Halberthal M, Shaked Y, Ben-Aharon I. Goshen-Lago T, et al. Among authors: shaked y. Cancers (Basel). 2020 Aug 26;12(9):2421. doi: 10.3390/cancers12092421. Cancers (Basel). 2020. PMID: 32859016 Free PMC article.

2

Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.

Timaner M, Letko-Khait N, Kotsofruk R, Benguigui M, Beyar-Katz O, Rachman-Tzemah C, Raviv Z, Bronshtein T, Machluf M, Shaked Y. Timaner M, et al. Among authors: shaked y. Cancer Res. 2018 Mar 1;78(5):1253-1265. doi: 10.1158/0008-5472.CAN-17-1547. Epub 2018 Jan 4. Cancer Res. 2018. PMID: 29301792 Free PMC article.

3

Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach.

Benguigui M, Alishekevitz D, Timaner M, Shechter D, Raviv Z, Benzekry S, Shaked Y. Benguigui M, et al. Among authors: shaked y. Oncotarget. 2017 Dec 20;9(2):2574-2590. doi: 10.18632/oncotarget.23514. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416793 Free PMC article.

4

Copper oxide loaded PLGA nanospheres: towards a multifunctional nanoscale platform for ultrasound-based imaging and therapy.

Perlman O, Weitz IS, Sivan SS, Abu-Khalla H, Benguigui M, Shaked Y, Azhari H. Perlman O, et al. Among authors: shaked y. Nanotechnology. 2018 May 4;29(18):185102. doi: 10.1088/1361-6528/aab00c. Epub 2018 Feb 16. Nanotechnology. 2018. PMID: 29451124

5

Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells.

Benguigui M, Weitz IS, Timaner M, Kan T, Shechter D, Perlman O, Sivan S, Raviv Z, Azhari H, Shaked Y. Benguigui M, et al. Among authors: shaked y. Sci Rep. 2019 Aug 30;9(1):12613. doi: 10.1038/s41598-019-48959-8. Sci Rep. 2019. PMID: 31471546 Free PMC article.

6

Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.

Khan KA, Ponce de Léon JL, Benguigui M, Xu P, Chow A, Cruz-Muñoz W, Man S, Shaked Y, Kerbel RS. Khan KA, et al. Among authors: shaked y. NPJ Breast Cancer. 2020 Jul 20;6:29. doi: 10.1038/s41523-020-0171-1. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 32704531 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 33574300

8

Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors.

Waldhorn I, Holland R, Goshen-Lago T, Shirman Y, Szwarcwort-Cohen M, Reiner-Benaim A, Shachor-Meyouhas Y, Hussein K, Fahoum L, Peer A, Almog R, Shaked Y, Halberthal M, Ben-Aharon I. Waldhorn I, et al. Among authors: shaked y. Cancer Discov. 2021 Oct;11(10):2430-2435. doi: 10.1158/2159-8290.CD-21-1072. Epub 2021 Sep 2. Cancer Discov. 2021. PMID: 34475136 Clinical Trial.

9

Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors.

Waldhorn I, Holland R, Goshen-Lago T, Benguigui M, Halberthal M, Shaked Y, Ben-Aharon I. Waldhorn I, et al. Among authors: shaked y. JAMA Oncol. 2022 Jun 1;8(6):1-2. doi: 10.1001/jamaoncol.2022.1467. JAMA Oncol. 2022. PMID: 35452089 No abstract available.

10

Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors.

Benguigui M, Vorontsova A, Timaner M, Levin S, Haj-Shomaly J, Deo A, Menachem R, Manobla B, Cooper TJ, Raviv Z, Shaked Y. Benguigui M, et al. Among authors: shaked y. Front Immunol. 2022 Jul 7;13:903591. doi: 10.3389/fimmu.2022.903591. eCollection 2022. Front Immunol. 2022. PMID: 35874722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page